Clinical Trials Directory

Trials / Completed

CompletedNCT00560898

Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function

Comparison of Two Multi-Purpose Solution and Contact Lens Material Combinations on Human Corneal Barrier Function

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Southern California College of Optometry at Marshall B. Ketchum University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to measure the relative "barrier" function of the top layer of the cornea (called the epithelium), or the degree to which the cornea can prevent the penetration of the colored dye sodium fluorescein into the eye. This is a clinical investigation of the effect on corneal barrier function following wear of two contact lens materials and two contact lens care systems, approved for marketing in the US by the Food and Drug Administration. These contact lenses will be worn for two hours, following soak in one of two marketed contact lens disinfecting solutions. Approximately 25 young, adapted contact lens wearers will participate.

Conditions

Interventions

TypeNameDescription
DRUGProClear Lens Material soaked in ReNu Multiplus Multipurpose SolutionContact lens soaked in multipuprpose solution for 8 hours, then worn for two hours
DRUGAcuvue Advance Lens Material soaked in ReNu Multiplus Multipurpose SolutionContact lens soaked in multipuprpose solution for 8 hours, then worn for two hours
DRUGAcuvue Advance Lens Material soaked in Optifree RepleniSH Multipurpose SolutionContact lens soaked in multipuprpose solution for 8 hours, then worn for two hours
DRUGProClear Lens Material soaked in Optifree RepleniSH Multipurpose SolutionContact lens soaked in multipuprpose solution for 8 hours, then worn for two hours

Timeline

Start date
2007-09-01
Primary completion
2007-12-01
Completion
2008-03-01
First posted
2007-11-20
Last updated
2008-05-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00560898. Inclusion in this directory is not an endorsement.